Back to Stakeholders
Categories

1 domain / 2 areas / 2 specializations

Research, Drug Development & Manufacturing
Clinical Trial InfrastructureSite Networks & SMOsSpecialized Trial Services
Research, Drug Development & Manufacturing

PsyCORE

Data updated

Psychedelic clinical research consortium concept focused on SOP harmonization, site onboarding, patient registry workflows, and study-operations support, with limited external corroboration.

Clinical Trial Infrastructure Snapshot

Specialized Trial Services

Service Model

Specialized Service Provider

Service Coverage

Global

Psychedelic Experience

Claimed Psychedelic Trial Experience

Last Source Check

Jun 18, 2026

Public Sources

4

Lifecycle Coverage

Feasibility & Protocol DesignStudy Startup & Site ActivationRecruitment & RetentionTrial Operations & MonitoringData Management & Biostatistics

Phase Coverage

Phase IPhase IIPhase III

Capabilities

Site Network AccessPatient Recruitment MediaDecentralized Trial Delivery

Research Update

Public-source profile available

Last checked Jun 18, 2026 across 4 sources.

Search Finding

Consortium model with SOPs, onboarding, registry, and site enablement, but limited external corroboration.

Source Caution

Concept and self-description fit CTI, but public evidence remains thin and operating geography is not verified.

Primary Service Link

Service Notes

Keep in the database as a needs-review infrastructure record. Do not assign catchment until physical sites or live operational locations are verified.

Source Evidence

PsyCORE — About

https://psy-core.org/

PsyCORE — Sites

https://psy-core.org/sites/

PsyCORE — Patients

https://psy-core.org/patients/

PsyCORE — Industry

https://psy-core.org/industry/

Quick Facts

Website
Visit